These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22763627)

  • 1. The effects of the combined use of a PDE5 inhibitor and medications for hypertension, lower urinary tract symptoms and dyslipidemia on corporal tissue tone.
    Lee JH; Chae MR; Park JK; Jeon JH; Lee SW
    Int J Impot Res; 2012; 24(6):221-7. PubMed ID: 22763627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue.
    Oger S; Behr-Roussel D; Gorny D; Lecoz O; Lebret T; Denoux Y; Faix A; Leriche A; Wayman C; Alexandre L; Giuliano F
    J Sex Med; 2009 Mar; 6(3):836-47. PubMed ID: 19143907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.
    Angulo J; Cuevas P; Fernández A; La Fuente JM; Allona A; Moncada I; Sáenz de Tejada I
    J Sex Med; 2012 Sep; 9(9):2293-306. PubMed ID: 22759598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of doxazosin with and without rho-kinase inhibitor on human corpus cavernosum smooth muscle in the presence of bladder outlet obstruction.
    Demir O; Murat N; Aslan G; Gidener S; Esen AA
    J Urol; 2006 Jun; 175(6):2345-9. PubMed ID: 16697871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence.
    Martínez-Salamanca JI; Carballido J; Eardley I; Giuliano F; Gratzke C; Rosen R; Salonia A; Stief C
    Eur Urol; 2011 Sep; 60(3):527-35. PubMed ID: 21684677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
    Chung MS; Lee SH; Park KK; Yoo SJ; Chung BH
    Int J Clin Pract; 2011 Nov; 65(11):1193-9. PubMed ID: 21995695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with hypotensive agents affects the impaired relaxation of the penile corpus cavernosum in hypertensive rats.
    Ushiyama M; Kuramochi T; Katayama S
    Hypertens Res; 2006 Jul; 29(7):523-32. PubMed ID: 17044665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates.
    Buono R; Briganti A; Freschi M; Villa L; La Croce G; Moschini M; Benigni F; Castiglione F; Montorsi F; Hedlund P
    Eur J Pharmacol; 2014 Dec; 744():42-51. PubMed ID: 25261033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson CC
    BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle.
    Erden Y; Korgalı E; Dundar G; Ayan S; Gokce G; Yildirim S; Gultekin EY
    Arch Ital Urol Androl; 2014 Mar; 86(1):33-8. PubMed ID: 24704929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ginkgo biloba extracts with mirodenafil on the relaxation of corpus cavernosal smooth muscle and the potassium channel activity of corporal smooth muscle cells.
    Kim JJ; Han DH; Lim SH; Kim TH; Chae MR; Chung KJ; Kam SC; Jeon JH; Park JK; Lee SW
    Asian J Androl; 2011 Sep; 13(5):742-6. PubMed ID: 21478894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
    Seo KK; Lee MY; Lim SW; Kim SC
    J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update.
    Zhang WH; Zhang XH
    Asian J Androl; 2016; 18(5):723-31. PubMed ID: 26620458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    Giuliano F; Ückert S; Maggi M; Birder L; Kissel J; Viktrup L
    Eur Urol; 2013 Mar; 63(3):506-16. PubMed ID: 23018163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.
    Gu N; Kim J; Lim KS; Shin KH; Kim TE; Lee B; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1929-39. PubMed ID: 22921287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide.
    Kalsi JS; Kell PD; Cellek S; Ralph DJ
    Int J Impot Res; 2004 Apr; 16(2):195-200. PubMed ID: 14961060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPH/LUTS and ED: common pharmacological pathways for a common treatment.
    Fusco F; D'Anzeo G; Sessa A; Pace G; Rossi A; Capece M; d'Emmanuele di Villa Bianca R
    J Sex Med; 2013 Oct; 10(10):2382-93. PubMed ID: 23875757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management.
    Orabi H; Albersen M; Lue TF
    Int J Impot Res; 2011; 23(3):99-108. PubMed ID: 21593760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.